Dr. Roberta Marongiu research focuses on developing novel gene therapy approaches for Parkinson's disease.
Dr. Marongiu’s current research focuses on the genetic causes of Parkinson’s disease and the development of new adeno-associated virus vector (AAV)-mediated brain gene therapies for Parkinson’s disease. She is studying the role of the P11 gene (S100A10) in dopaminergic-mediated motor striatal activity and Levodopa-induced dyskinesias and the molecular pathways through which P11 modulates the physiological effects of dopamine on their target neurons in basal ganglia.
Roberta has had the passion for genetics and neuroscience since she was a teenager. She obtained her Ph.D. in Medic...